An MRI-based approach to prostate cancer diagnosis: a urologist’s stance in the debate

An MRI-based approach to prostate cancer diagnosis: a urologist’s stance in the debate

VJOncology

1 year
98 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
The first study illustrating the potential of MRI in the diagnosis of prostate cancer was published in 2006. Although there have since been a number of other studies showing this utility, the use of MRI in this field is still debated. Here, Mark Emberton, MD, FRCS, of University College London, London, UK, discusses the debate he took part in on this topic at the 2018 Genitourinary Cancers Symposium, in San Francisco, CA. Speaking from the meeting, Prof. Emberton discusses the results of randomized clinical trials, which he presented to support his case for this technology, including the the PROstate Mri Imaging Study (PROMIS; NCT01292291). He also highlights a further study, which is due to be presented at the Annual European Association of Urology (EAU) Congress 2018.
Up Next Autoplay
Treatment-Free Survival, With and Without Toxicity
Treatment-Free Survival, With and Without Toxicity
Category: Kidney Cancer
0 Views
kidneycancer 34 minutes
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Category: Kidney Cancer
0 Views
kidneycancer 50 minutes
What's To Come in Modern Imaging Technology
What's To Come in Modern Imaging Technology
Category: Kidney Cancer
1 Views
kidneycancer 20 hours
Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia
Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia
Category: Acute Myelogenous Leukemia
4 Views
Cancer-News 23 hours
CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial
CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial
Category: Breast Cancer
6 Views
Cancer-News 1 day
Modern Imaging Technology
Modern Imaging Technology
Category: Kidney Cancer
3 Views
kidneycancer 1 day
ASH Releases New Clinical Practice Guidelines on Immune Thrombocytopenia
ASH Releases New Clinical Practice Guidelines on Immune Thrombocytopenia
Category: News
2 Views
Cancer-News 1 day
Management of Clinical Cases in Kidney Cancer
Management of Clinical Cases in Kidney Cancer
Category: Kidney Cancer
4 Views
kidneycancer 2 days
Kidney Cancer Program & SPORE
Kidney Cancer Program & SPORE
Category: Kidney Cancer
1 Views
kidneycancer 2 days
Researchers Find Common Measures of Immune Status, Inflammation Can Predict Mortality
Researchers Find Common Measures of Immune Status, Inflammation Can Predict Mortality
Category: News
4 Views
Cleveland Clinic 2 days